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 Introduction 
 Acute kidney injury (AKI) is particularly common 
among the elderly  [1] . Pre-existing chronic kidney disease 
(CKD) is arguably the strongest risk factor for AKI  [2] . 
Here, we review the recent literature on the relationship 
between AKI and CKD in elderly patients.
 CKD and Predisposition to AKI  
 There has been considerable debate recently about the 
definition of ‘chronic kidney disease’ in elderly patients 
[see Winearls and Glassock, pp. c2–c4 this issue]. Doubts 
have been raised whether an estimated glomerular filtra-
tion rate (eGFR) cutoff of 60 ml/min/1.73 m 2 is appropri-
ate to define CKD in all segments of the population, es-
pecially among the elderly, since there is a natural age-
associated decline in renal function  [3] . To inform this 
debate, one major thrust of active research in the CKD 
field is to better define the association between levels of 
eGFR and clinical outcomes  [4] . To address the issue of 
CKD classification in the elderly, numerous papers have 
examined outcomes such as cardiovascular disease events 
(e.g. myocardial infarction or congestive heart failure) 
and mortality in age-stratified analyses  [5–7] . 
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 Abstract 
 There have been considerable advances in the past few years 
in our understanding of how chronic kidney disease (CKD) 
predisposes to acute kidney injury (AKI) and vice versa. This 
review shows, however, that few studies have focused on the 
elderly or conducted stratified analysis by age. It does ap-
pear that elderly patients with estimated glomerular filtra-
tion rate (eGFR) 45–59 ml/min/1.73 m 2 are at higher risk for 
AKI compared with their counterparts with eGFR  1 60 ml/
min/1.73 m 2 . This is a similar relationship to that seen in 
younger patients, although effect size appears smaller. As 
the incidence of AKI has been increasing over the past sev-
eral years, the proportion of elderly patients surviving after 
AKI has also been increasing. Since AKI heightens the risk for 
the development and acceleration of CKD, this implies sig-
nificant public health concerns with regard to the absolute 
number of elderly persons developing incident CKD. 
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 However, until recently, no published study examined 
AKI as an outcome, even though a strong argument can 
be made that AKI compared to cardiovascular disease
is more directly linked pathophysiologically to CKD. 
Therefore, any observed association between CKD and 
AKI is less likely to be due to confounding than analo-
gous associations between CKD and cardiovascular dis-
ease  [8] .
 A 2008 paper by Hsu et al.  [2]  quantified how risk of 
dialysis-requiring AKI varied by severity of preexisting 
CKD among a large cohort of patients receiving usual 
medical care in a Northern California integrated health 
care delivery system. That study found that an increase 
in risk of AKI becomes apparent starting below an eGFR 
of 60 ml/min/1.73 m 2 . Even subjects with an  eGFR 45–
59 ml/min/1.73 m 2 have on average a two-fold increase 
in adjusted odds ratio of AKI compared with subjects 
with an eGFR of 60 ml/min/1.73 m 2 or above – with risk 
being higher among subjects with diabetes than among 
those without ( fig. 1 ). These data support the  National 
Kidney Foundation Chronic Kidney Disease Guidelines 
in which persons with eGFRs chronically below 60 ml/
min/1.73 m 2 are classified as having CKD, regardless of 
other factors. Further age stratification analyses showed 
that the adjusted odds ratio was 2.73 (95% CI 2.12–3.51; 
p  ! 0.0001) for those aged  ^  65 years, comparing pa-
tients with eGFR 45–59 ml/min/1.73 m 2 with their 
counterparts with eGFR  6 60 ml/min/1.73 m 2 ; for pa-
tients aged  1 65 years, the corresponding adjusted odds 
ratio was 1.33 (95% CI 1.08–1.64; p = 0.008) [unpubl. 
data]. 
 A recent publication by Grams et al.  [9]  using data 
from the Atherosclerosis Risk in Communities (ARIC) 
Study obtained similar results. For example, the adjusted 
risk of AKI approximately doubled going from an eGFR 
of 60 to 45 ml/min/1.73 m 2 . Interestingly, Grams et al., 
who used the CKD-EPI equation  [10] to explore higher 
eGFR levels, reported that compared with those with 
eGFR 75 ml/min/1.73 m 2 , relative hazards for AKI was 
nearly doubled in ARIC participants with eGFR of 60 ml/
min/1.73 m 2 . This is a stronger and earlier signal than 
that seen in numerous studies of eGFR and death or car-
diovascular disease – where in some instances risk may 
not rise appreciably until eGFR is below 45 ml/min/1.73 
m 2  [11–13] . This argues that the NKF threshold of an 
eGFR of 60 ml/min/1.73 m 2 may actually be too conser-
vative in some clinical settings such as AKI. No age-strat-
ified eGFR analysis was presented by Grams et al.  [9] . 
 In addition to a low eGFR, the other main manifesta-
tion of CKD is proteinuria and the importance of protein-
uria in the classification of CKD has received much atten-
tion recently. Hsu et al.  [2] first reported that proteinuria 
is an important independent risk factor for AKI. Patients 
with documented dipstick proteinuria appear to be 2–3 
times as likely as patients without it to develop AKI, in-
dependent of eGFR. Grams et al.  [9]  further quantified a 
graded relationship between severity of proteinuria (al-
buminuria) and risk of AKI. With participants who had 
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 Fig. 1. Multivariable association of base-
line eGFR and dialysis-requiring acute 
kidney injury stratified by the presence or 
absence of diabetes mellitus (DM) [modi-
fied from ref.  2 ]. 
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urine albumin-to-creatinine ratios  ! 10 mg/g as a refer-
ence, the adjusted hazards ratios of AKI were 1.9, 2.2, and 
4.8 for urine albumin-to-creatinine ratio groups of 11–29, 
30–299 and  6 300 mg/g, respectively. Age-stratified anal-
ysis showed that the associations between crude rates of 
AKI and severity of baseline albuminuria were similar in 
those above or below age 65 years ( fig. 2 ).
 Several other recent studies have also concluded that 
proteinuria is a risk factor for AKI in the setting of car-
diac catheterization  [14] , cardiac surgery  [15] and in the 
general population  [16] . But no comparisons of older and 
younger patients were reported. 
 AKI and Predisposition to CKD  
 A plethora of data over the past several years, both 
from experimental studies in animals and from human 
studies, indicates that AKI not infrequently leads to CKD. 
 In experimental animals, a robust fibrotic response in 
the kidney is apparent several days to weeks after a single 
episode of AKI induced by ischemia-reperfusion injury 
 [17, 18] . This fibrotic response is enhanced by older age 
 [19] . The primary mediator of this relationship is multi-
factorial, implicating microvascular damage  [17] , in-
creased sensitivity to angiotensin II  [20] and upregula-
tion of genes associated with inflammation, remodeling 
and fibrosis  [21, 22] . In aged mice, expression of zinc-  2 -
glycoprotein may influence the exaggerated fibrotic re-
sponse  [19] . A significant manifestation of the post-AKI 
injury phenotype is salt-sensitive hypertension  [23, 24] . 
 The preponderance of evidence from epidemiologic 
studies supports the notion that AKI leads to CKD in el-
derly persons. First, older age is associated with a greater 
chance of nonrecovery of renal function back to baseline 
after AKI by the time of hospital discharge  [25] . Second, 
several studies have demonstrated that even after adjust-
ment for several important covariates, AKI is indepen-
dently associated with an increased risk for both CKD 
and end-stage renal disease (ESRD) ( table 1 ). In elderly 
patients, the risk for ESRD after a single episode of AKI 
is elevated 2-fold in those with mild AKI  [26] , and elevat-
ed by 3- to 13-fold in those with more severe AKI  [16, 
26–28] . The annual absolute risk for developing ESRD is 
approximately 0.6–1.2% after mild AKI  [14, 26] , but 1.7–
2.9% after severe AKI  [14, 26–28] . The annualized risk of 
ESRD increases to 7–9% if the AKI occurs in an individ-
ual with a preexisting history of CKD  [16, 27, 28] . The 
 relative risk for ESRD may  [28] or may not  [27] be higher 
in those of older age (vs. younger age) after AKI. If the 
latter is true (lower relative risk of ESRD with older age 
vs. younger age), the effect is likely confounded by the 
competing risk of death. 
 ESRD only represents the most severe manifestation 
of CKD. Less severe stages of CKD are still associated 
with a markedly increased risk of cardiovascular disease, 
poorer quality of life and increased health care costs  [11] . 
The incidence rate of CKD (stage 4 or worse) is approxi-
mately 120 per 1,000 person-years after non-dialysis-re-
quiring AKI  [29] and 479 per 1,000 person-years in those 
who required dialysis for AKI  [30] . These absolute inci-
dence rates are commensurate with adjusted hazard ra-
tios of at least 4 for non-dialysis-requiring AKI and 28 for 
dialysis-requiring AKI (compared to no AKI, respective-
ly)  [29, 30] . 
 In a recent study examining the rate of eGFR decline 
in patients undergoing cardiac catheterization, James et 
al.  [14]  demonstrated that the rate of decline in eGFR was 
1.0 ml/min/1.73 m 2 per year after mild AKI and 2.8 ml/
min/1.73 m 2 per year after moderate or severe AKI (com-
pared with 0.1 ml/min/1.73 m 2 per year in those without 
AKI). Although these rates were adjusted for age (along 
with proteinuria and comorbidities), it is unclear wheth-
er older age was associated with a more rapid decline of 
eGFR, as would be hypothesized based on data from ex-
perimental animals. Factors that clearly modify the ef-
fects of the relationship between AKI and progressive 
CKD are level of baseline renal function and degree of 
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 Fig. 2. Incidence rates of acute kidney injury by level of baseline 
albuminuria, stratified by age above or below 65 years [modified 
from ref.  9 ]. UACR = Urine albumin-to-creatinine ratio.  
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proteinuria  [16] . The risk for progressive CKD attribut-
able to AKI attenuates with lower levels of baseline eGFR 
and higher levels of proteinuria. 
 With regard to public health, approximately 40 mil-
lion people in the US are aged  6 65 in 2010. Since the in-
cidence of AKI in this elderly population is approximate-
ly 3,000 per 100,000 person-years  [1] and 75% will survive 
to discharge after AKI, and the incidence of stage 4 or 
worse CKD after AKI is approximately 120 per 1,000 per-
son-years [estimated from Kaplan-Meier curve in figure 
3 of reference 29] then approximately 100,000 elderly per-
sons per year in the United States are developing new 
CKD after an episode of AKI. Clearly, the challenges for 
the nephrology community are to find strategies to either 
Table 1.  Adjusted rate ratios for ESRD or doubling of serum creatinine by baseline kidney function and proteinuria
Study Setting Patients
n
AKI definition ESRD Comments
incidence rate
person-years
adjusted HR
Amdur
et al.
[29]
hospitalized 
veterans
113,272 ICD-9 codes
ATN
ARF
controls (no AKI)
CKD without AKI
20.0%a
13.2%a
3.3%a
24.7%a
6.64a
4.03a
1.0a
6.5a
mean ages by group, years
63.8
66.5
68.7
74.4
No age-specific analyses reported
Hsu et al.
[34] 
hospitalized 
with pre-
existing CKD
39,805 acute dialysis 12.7% at
6 months
1.47 (0.95–2.28) mean age 66.6 years in those with AKI
no age-specific analyses reported
Ishani
et al.
[27] 
Medicare 233,803 ICD-9 based:
AKI
AKI on CKD
27.5/1,000
101.5/1,000
13.0 (11.0–16.0)
41.2 (34.6–49.1)
incidence rate; adjusted HR for ESRD by age strata 
(total population; not by AKI/no AKI)
age, years:
67–70: 8/1,000; 1.0
71–75: 6.9/1,000; 0.87 (0.74–1.02)
76–80: 5.7/1,000; 0.72 (0.61–0.85)
81–85: 4.3/1,000; 0.63 (0.52–0.76)
≥ 86: 1.9/1,000; 0.36 (0.28–0.46)
Lo et al.
[30]
population-
based cohort
3,773 in-hospital dialysis 
vs. matched non-
AKI
479/1,000b
17/1,000b
28.1 (21.1–37.6)b mean age of AKI 63.5
no age-specific analyses reported
Newsome 
et al.
[26]
Medicare-
Acute MI
87,094 change in SCr:
None
Cr d 0.1
Cr d 0.2 
Cr d 0.3–0.5
Cr d 0.6–3.0
2.3/1,000
2.3/1,000
3.6/1000
6.3/1,000
20.0/1,000
1.0 
1.45 
1.97
2.36
3.26
entire cohort was aged ≥67
no age-specific analyses reported
Wald
et al.
[28]
population-
based cohort
17,367 in-hospital dialysis 
vs. matched non-
AKI
26/1,000
9/1,000
3.23 (2.7–3.86) absolute risk and excess risk for ESRD after AKI 
higher in patients aged ≥65 (AKI 9.5% vs. non-
AKI 2.8%) compared to those aged <65 (7.4 vs. 
3.2%) 
James
et al.
[14] 
coronary 
angiography
11,249 no AKI
mild AKI
moderate/severe 
AKI
3.7%c
9.4%c
21.8%c
1.0
1.60 (1.19–2.14)
3.12 (1.95–4.99)
mean age 67 in those with AKI
no age-specific analyses reported
James
et al.
[16] 
population-
based cohort
920,985 AKI (ICD-9 and
-10) vs. no AKI
3.5/1,000d
0.78/1,000d
21–230, depending on 
baseline GFR and 
degree of proteinuria
no age-specific analyses reported
Figures shown in parentheses are 95% CI. ATN = Acute tubular necro-
sis; ARF = acute renal failure.
a Cumulative incidence at 20% percentile follow-up of 10.9 months in 
ATN and 57 months in ARF. b Endpoint was CKD stage 4 or higher. 
c Cumulative incidence with median follow-up of 21 months for composite 
endpoint of decline in eGFR >4 ml/min/1.73 m2 or ESRD. d Endpoint was 
ESRD or doubling of serum creatinine (SCr).
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prevent AKI or prevent the transition from AKI to CKD. 
Until these strategies are developed and proven to be ef-
fective, CKD and ESRD after AKI in elderly patients rep-
resent a substantial public health burden. 
 Conclusion 
 In summary, elderly patients with eGFR 45–59 ml/
min/1.73 m 2 are at higher risk for AKI compared with 
their counterparts with eGFR  1 60 ml/min/1.73 m 2 . This 
is a similar relationship to that seen in younger patients, 
although effect size appears smaller. As the incidence of 
AKI has been increasing over the past several years  [1] , 
the proportion of elderly patients surviving after AKI has 
also been increasing  [31–33] . Since AKI heightens the risk 
for the development and acceleration of CKD, this im-
plies significant public health concerns with regard to the 
absolute number of elderly persons developing incident 
CKD.
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